Navigation Links
Cord Blood America to Acquire or Build Its Own Stem Cell Laboratory
Date:5/7/2009

SANTA MONICA, Calif., May 7 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it has begun due diligence to either purchase or build its own secure cryogenic stem cell bank for the storage of multiple stem cell products including umbilical cord blood stem cells.

"Over the long term, having our own facility will reduce the cost for both the processing and storage of our clients' stem cells," said founder and CEO Matthew Schissler. "Additionally, it allows CBAI to pursue new sources of revenue such as the storage of adipose tissue and peripheral blood stem cells processing and storage, and research grants much quicker than under the current structure of outsourced relationships."

"We can't grow to the size and position we seek for the future without our own laboratory. This is an important strategic step to securing further industry leadership and differentiation," Mr. Schissler said.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

    CONTACT:
    Paul Knopick
    E & E Communications
    949/707-5365
    pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cord Blood America Supports Effort in Congress to Inform on Value of Umbilical Cord Blood Stem Cell Storage
2. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
3. Cord Blood America Further Reduction, $817,000, in Long-Term Debt
4. Cord Blood America Announces 2008 Financial Results
5. Metametrix Introduces the New TRIAD(SM) Bloodspot Profile
6. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
7. Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
8. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
9. Cord Blood America Sees Significant Positives in President Obamas Lifting of Stem Cell Funding Restrictions
10. Cord Blood America Restructures Debt; Projects to be Cash Flow Positive
11. In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2017)... ... 15, 2017 , ... The newest exhibition at the University ... experimentation and interdisciplinary collaboration. Feature Creep, a solo exhibition by Maximillian Lawrence, opens ... be held at EKG, located at 3600 Market Street in Philadelphia, on Thursday, ...
(Date:6/15/2017)... , ... June 15, 2017 , ... ... director for DuPont Biofuels, will be speaking at Bloomberg’s 2017 Sustainable Business ... join other leading environmental and sustainability officials on a panel titled “Developing a ...
(Date:6/14/2017)... (PRWEB) , ... June 14, 2017 , ... ... June 8th to discuss the initiative steered by the executive search firm, “Building ... Chairman of the Board of Directors of Foundation Medicine, led an open discussion ...
(Date:6/14/2017)... ... June 14, 2017 , ... Graphite Metallizing Corporation, the manufacturer ... appointed Andrew Ondish as Territory Sales Manager for New Jersey, Eastern Pennsylvania, Delaware, ... Engineering from Colorado School of Mines. With nearly thirty years of experience in ...
Breaking Biology Technology:
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 8.8% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):